Main variables;Main activity, secondary one or a tool necessary for production;Total
Companies that carry out R&D in Biotechnology;Total;304.0
Companies that carry out R&D in Biotechnology;Main;187.0
Companies that carry out R&D in Biotechnology;Secondary dwellings;295.0
Companies that carry out R&D in Biotechnology;Tool;786.0
%Companies according to biotechnology used: Genetic code;Total;56.9
%Companies according to biotechnology used: Genetic code;Main;35.0
%Companies according to biotechnology used: Genetic code;Secondary dwellings;23.1
%Companies according to biotechnology used: Genetic code;Tool;39.0
%Companies according to biotechnology used: Functional units;Total;55.7
%Companies according to biotechnology used: Functional units;Main;29.1
%Companies according to biotechnology used: Functional units;Secondary dwellings;16.5
%Companies according to biotechnology used: Functional units;Tool;34.7
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total;49.7
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Main;28.8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Secondary dwellings;20.4
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Tool;33.8
%Companies according to biotechnology used: Bioprocesses;Total;41.6
%Companies according to biotechnology used: Bioprocesses;Main;37.9
%Companies according to biotechnology used: Bioprocesses;Secondary dwellings;46.8
%Companies according to biotechnology used: Bioprocesses;Tool;42.7
%Companies according to biotechnology used: Sub-cellular organisms;Total;17.8
%Companies according to biotechnology used: Sub-cellular organisms;Main;6.6
%Companies according to biotechnology used: Sub-cellular organisms;Secondary dwellings;3.9
%Companies according to biotechnology used: Sub-cellular organisms;Tool;10.0
%Companies according to biotechnology used: Bio-computing;Total;26.7
%Companies according to biotechnology used: Bio-computing;Main;14.1
%Companies according to biotechnology used: Bio-computing;Secondary dwellings;6.9
%Companies according to biotechnology used: Bio-computing;Tool;16.3
%Companies according to biotechnology used: Nanobiotechnology;Total;14.8
%Companies according to biotechnology used: Nanobiotechnology;Main;6.9
%Companies according to biotechnology used: Nanobiotechnology;Secondary dwellings;4.4
%Companies according to biotechnology used: Nanobiotechnology;Tool;9.0
%Companies according to biotechnology used: Other;Total;12.2
%Companies according to biotechnology used: Other;Main;23.2
%Companies according to biotechnology used: Other;Secondary dwellings;24.7
%Companies according to biotechnology used: Other;Tool;19.5
%Company by field(s) of ultimate application of biotechnology use: Human Health;Total;67.9
%Company by field(s) of ultimate application of biotechnology use: Human Health;Main;45.9
%Company by field(s) of ultimate application of biotechnology use: Human Health;Secondary dwellings;21.7
%Company by field(s) of ultimate application of biotechnology use: Human Health;Tool;45.4
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;24.7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Main;22.7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Secondary dwellings;14.7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Tool;20.5
%Company by field(s) of ultimate application of biotechnology use: Food products;Total;29.8
%Company by field(s) of ultimate application of biotechnology use: Food products;Main;30.5
%Company by field(s) of ultimate application of biotechnology use: Food products;Secondary dwellings;46.9
%Company by field(s) of ultimate application of biotechnology use: Food products;Tool;36.4
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Total;21.5
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Main;17.7
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Secondary dwellings;23.4
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Tool;21.3
%Company by field(s) of ultimate application of biotechnology use: Environment;Total;17.1
%Company by field(s) of ultimate application of biotechnology use: Environment;Main;27.9
%Company by field(s) of ultimate application of biotechnology use: Environment;Secondary dwellings;15.4
%Company by field(s) of ultimate application of biotechnology use: Environment;Tool;19.1
%Company by field(s) of ultimate application of biotechnology use: Industry;Total;16.8
%Company by field(s) of ultimate application of biotechnology use: Industry;Main;17.3
%Company by field(s) of ultimate application of biotechnology use: Industry;Secondary dwellings;9.4
%Company by field(s) of ultimate application of biotechnology use: Industry;Tool;14.1
Personnel in R&D in biotechnology (no. of persons);Total;4,037.0
Personnel in R&D in biotechnology (no. of persons);Main;1,386.0
Personnel in R&D in biotechnology (no. of persons);Secondary dwellings;1,542.0
Personnel in R&D in biotechnology (no. of persons);Tool;6,965.0
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;2,334.0
Personnel in R&D in biotechnology (no. of persons): Researchers;Main;832.0
Personnel in R&D in biotechnology (no. of persons): Researchers;Secondary dwellings;765.0
Personnel in R&D in biotechnology (no. of persons): Researchers;Tool;3,931.0
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;1,703.0
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Main;554.0
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Secondary dwellings;777.0
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Tool;3,034.0
Personnel in R&D in biotechnology (no. of persons): women;Total;2,419.0
Personnel in R&D in biotechnology (no. of persons): women;Main;745.0
Personnel in R&D in biotechnology (no. of persons): women;Secondary dwellings;755.0
Personnel in R&D in biotechnology (no. of persons): women;Tool;3,919.0
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;1,295.0
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Main;448.0
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Secondary dwellings;370.0
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Tool;2,113.0
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;1,124.0
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Main;297.0
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Secondary dwellings;385.0
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Tool;1,806.0
Personnel in R&D in biotechnology (FTE);Total;3,502.0
Personnel in R&D in biotechnology (FTE);Main;880.2
Personnel in R&D in biotechnology (FTE);Secondary dwellings;950.1
Personnel in R&D in biotechnology (FTE);Tool;5,332.3
Personnel in R&D in biotechnology (FTE): Researchers;Total;2,023.9
Personnel in R&D in biotechnology (FTE): Researchers;Main;548.8
Personnel in R&D in biotechnology (FTE): Researchers;Secondary dwellings;508.7
Personnel in R&D in biotechnology (FTE): Researchers;Tool;3,081.4
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;1,478.1
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Main;331.5
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Secondary dwellings;441.4
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Tool;2,251.0
Personnel in R&D in biotechnology (FTE): women;Total;2,111.6
Personnel in R&D in biotechnology (FTE): women;Main;501.1
Personnel in R&D in biotechnology (FTE): women;Secondary dwellings;493.0
Personnel in R&D in biotechnology (FTE): women;Tool;3,105.7
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;1,139.9
Personnel in R&D in biotechnology (FTE): (women) Researchers;Main;312.9
Personnel in R&D in biotechnology (FTE): (women) Researchers;Secondary dwellings;253.8
Personnel in R&D in biotechnology (FTE): (women) Researchers;Tool;1,706.6
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;971.7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Main;188.2
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Secondary dwellings;239.2
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Tool;1,399.1
Internal expenditure on R&D (thousands of euros);Total;350,072.0
Internal expenditure on R&D (thousands of euros);Main;78,300.0
Internal expenditure on R&D (thousands of euros);Secondary dwellings;59,884.0
Internal expenditure on R&D (thousands of euros);Tool;488,256.0
1) By nature of the expense: Current expenses;Total;298,605.0
1) By nature of the expense: Current expenses;Main;51,463.0
1) By nature of the expense: Current expenses;Secondary dwellings;51,882.0
1) By nature of the expense: Current expenses;Tool;401,949.0
1.1) Remuneration to researchers;Total;95,484.0
1.1) Remuneration to researchers;Main;24,533.0
1.1) Remuneration to researchers;Secondary dwellings;22,817.0
1.1) Remuneration to researchers;Tool;142,834.0
1.2) Remuneration to technicians and assistants;Total;54,105.0
1.2) Remuneration to technicians and assistants;Main;10,023.0
1.2) Remuneration to technicians and assistants;Secondary dwellings;12,839.0
1.2) Remuneration to technicians and assistants;Tool;76,966.0
1.3) Other current expenses;Total;149,015.0
1.3) Other current expenses;Main;16,907.0
1.3) Other current expenses;Secondary dwellings;16,227.0
1.3) Other current expenses;Tool;182,149.0
2) By nature of the expense: Capital expenses;Total;51,468.0
2) By nature of the expense: Capital expenses;Main;26,837.0
2) By nature of the expense: Capital expenses;Secondary dwellings;8,002.0
2) By nature of the expense: Capital expenses;Tool;86,307.0
2.1) Land and buildings;Total;17,198.0
2.1) Land and buildings;Main;13,889.0
2.1) Land and buildings;Secondary dwellings;2,765.0
2.1) Land and buildings;Tool;33,852.0
2.2) Equipment and instruments;Total;31,345.0
2.2) Equipment and instruments;Main;12,521.0
2.2) Equipment and instruments;Secondary dwellings;5,082.0
2.2) Equipment and instruments;Tool;48,948.0
2.3) Acquisition of specific R+D software;Total;2,925.0
2.3) Acquisition of specific R+D software;Main;427.0
2.3) Acquisition of specific R+D software;Secondary dwellings;155.0
2.3) Acquisition of specific R+D software;Tool;3,507.0
1) By origin of the funds: National funds;Total;308,700.0
1) By origin of the funds: National funds;Main;75,453.0
1) By origin of the funds: National funds;Secondary dwellings;59,346.0
1) By origin of the funds: National funds;Tool;443,500.0
1.1) Own funds;Total;220,904.0
1.1) Own funds;Main;42,434.0
1.1) Own funds;Secondary dwellings;42,164.0
1.1) Own funds;Tool;305,502.0
1.2) From companies;Total;15,453.0
1.2) From companies;Main;3,287.0
1.2) From companies;Secondary dwellings;4,927.0
1.2) From companies;Tool;23,667.0
1.3) Public Administration funds;Total;70,496.0
1.3) Public Administration funds;Main;29,549.0
1.3) Public Administration funds;Secondary dwellings;12,151.0
1.3) Public Administration funds;Tool;112,196.0
1.4) From Universities;Total;115.0
1.4) From Universities;Main;112.0
1.4) From Universities;Secondary dwellings;87.0
1.4) From Universities;Tool;314.0
1.5) From non profit private institutions;Total;1,733.0
1.5) From non profit private institutions;Main;71.0
1.5) From non profit private institutions;Secondary dwellings;18.0
1.5) From non profit private institutions;Tool;1,822.0
1) By origin of the funds: Foreign funds;Total;41,372.0
1) By origin of the funds: Foreign funds;Main;2,846.0
1) By origin of the funds: Foreign funds;Secondary dwellings;538.0
1) By origin of the funds: Foreign funds;Tool;44,756.0
2.1) From EU programmes;Total;4,761.0
2.1) From EU programmes;Main;1,362.0
2.1) From EU programmes;Secondary dwellings;378.0
2.1) From EU programmes;Tool;6,501.0
2.2) Other foreign funds;Total;36,611.0
2.2) Other foreign funds;Main;1,485.0
2.2) Other foreign funds;Secondary dwellings;160.0
2.2) Other foreign funds;Tool;38,256.0
Purchase of R&D services in biotechnology (thousands of euros);Total;48,888.0
Purchase of R&D services in biotechnology (thousands of euros);Main;5,780.0
Purchase of R&D services in biotechnology (thousands of euros);Secondary dwellings;6,931.0
Purchase of R&D services in biotechnology (thousands of euros);Tool;61,599.0
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Total;38,820.0
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Main;5,535.0
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Secondary dwellings;5,682.0
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Tool;50,036.0
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Total;10,068.0
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Main;245.0
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Secondary dwellings;1,249.0
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Tool;11,562.0
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;51.1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Main;47.4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Secondary dwellings;40.2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Tool;46.1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;11.0
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Main;12.2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Secondary dwellings;12.2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Tool;11.7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;18.3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Main;18.7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Secondary dwellings;14.3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Tool;16.9
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;23.8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Main;10.8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Secondary dwellings;18.3
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Tool;18.7
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Total;25.3
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Main;17.9
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Secondary dwellings;16.6
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Tool;20.3
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Total;26.7
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Main;16.5
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Secondary dwellings;15.9
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Tool;20.2
%Companies that consider the following obstacles as very important considering biotechnology development : Public acceptance / awareness;Total;19.1
%Companies that consider the following obstacles as very important considering biotechnology development : Public acceptance / awareness;Main;19.5
%Companies that consider the following obstacles as very important considering biotechnology development : Public acceptance / awareness;Secondary dwellings;18.7
%Companies that consider the following obstacles as very important considering biotechnology development : Public acceptance / awareness;Tool;19.0
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;34.5
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Main;25.4
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Secondary dwellings;26.0
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Tool;29.1
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Total;53.2
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Main;46.4
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Secondary dwellings;37.0
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Tool;45.5
%Companies that consider the following obstacles as very important considering biotechnology development : Patent rights belonging to third parties;Total;17.9
%Companies that consider the following obstacles as very important considering biotechnology development : Patent rights belonging to third parties;Main;18.7
%Companies that consider the following obstacles as very important considering biotechnology development : Patent rights belonging to third parties;Secondary dwellings;9.3
%Companies that consider the following obstacles as very important considering biotechnology development : Patent rights belonging to third parties;Tool;14.8
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;13.2
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Main;13.4
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Secondary dwellings;9.0
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Tool;11.7
% Companies that have requested biotechnology patents;Total;26.9
% Companies that have requested biotechnology patents;Main;10.0
% Companies that have requested biotechnology patents;Secondary dwellings;8.7
% Companies that have requested biotechnology patents;Tool;16.1
Number of patents requested;Total;187.0
Number of patents requested;Main;71.0
Number of patents requested;Secondary dwellings;48.0
Number of patents requested;Tool;306.0
% Companies with income of an international origin related to biotechnological activities;Total;25.0
% Companies with income of an international origin related to biotechnological activities;Main;16.9
% Companies with income of an international origin related to biotechnological activities;Secondary dwellings;6.6
% Companies with income of an international origin related to biotechnological activities;Tool;16.1
% Turnover representing income of an international origin related to biotechnological activities;Total;6.90
% Turnover representing income of an international origin related to biotechnological activities;Main;1.50
% Turnover representing income of an international origin related to biotechnological activities;Secondary dwellings;1.20
% Turnover representing income of an international origin related to biotechnological activities;Tool;2.80
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Total;43.50
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Main;64.70
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Secondary dwellings;44.40
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Tool;46.80
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Total;56.60
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Main;35.30
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Secondary dwellings;55.60
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Tool;53.20
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Total;94.20
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Main;97.50
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Secondary dwellings;99.70
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Tool;95.80
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total;0.20
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Main;0.70
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Secondary dwellings;.
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Tool;0.20
% Income of an international origin related with activities according to the classification: Operating source abroad;Total;0.40
% Income of an international origin related with activities according to the classification: Operating source abroad;Main;1.80
% Income of an international origin related with activities according to the classification: Operating source abroad;Secondary dwellings;0.20
% Income of an international origin related with activities according to the classification: Operating source abroad;Tool;0.50
% Income of an international origin related with activities according to the classification: Other;Total;5.30
% Income of an international origin related with activities according to the classification: Other;Main;.
% Income of an international origin related with activities according to the classification: Other;Secondary dwellings;0.10
% Income of an international origin related with activities according to the classification: Other;Tool;3.50